Jame Abraham

机构：Cleveland Clinic

发表论文 75 篇 · 总被引 991 次 · h-index 12

代表论文

• Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (2025 · New England Journal of Medicine · 被引 61)
• Overcoming endocrine resistance in breast cancer: role of the PI3K and the mTOR pathways (2013 · Expert Review of Anticancer Therapy · 被引 20)
• Linking Genetic Counseling Content to Short‐Term Outcomes in Individuals at Elevated Breast Cancer Risk (2014 · Journal of Genetic Counseling · 被引 15)
• Preclinical discovery and development of abemaciclib used to treat breast cancer (2020 · Expert Opinion on Drug Discovery · 被引 11)
• Efficacy of Solubilized Vemurafenib Administered via Nasogastric Tube (2014 · Future Oncology · 被引 8)
• Abstract PS12-16: Pilot study of carboplatin, nab-paclitaxel and pembrolizumab for metastatic triple-negative breast cancer (2021 · Cancer Research · 被引 3)